WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies and neurovascular disease, noted that in the past two months three new peer-reviewed journal articles have been published covering various aspects of the NC-stat System, providing further validation for the utility and accuracy of conventional nerve conduction studies performed with the NC-stat System.
